Health Rights and Patients
Please find all related articles below.
A new EPHA report examines the progress of the implementation of the 2011 Directive on the application of patients’ rights in cross-border healthcare (2011/24/EU). Following the European Commission’s own first review of the operation of the Directive, EPHA’s report calls for actions to ensure that the Directive does not exacerbate health inequalities by only working in favour of well-to-do patients and Member States. Among other measures this will entail tailored and (...)
The General Data Protection Reform (GDPR) entered into the trilogue phase in June with the aim of concluding discussions at the end of 2015 or soon thereafter. A new EPHA progress report describes the challenges of the GDPR experienced so far and confirms the crucial role of data for health research and science purposes.
In 2012, following the release of the European Commission’s proposal for a draft regulation (setting out a general EU framework for data protection) and a draft (...)
eHealth, mobile apps and digital medical services are sparking many hopes and concerns at the same time. The #Datacare debate held on 15 September 2015 at the European Parliament specifically explored the question, “What can data driven healthcare do for Europe?”
In our globalised, digital world, things are changing rapidly and technology is an inevitable, driving feature of innovation. In the future, health systems are likely to be permeated more and more by technology. Now is (...)
A new report released on 11 June 2015 by global consumer watchdog SumOfUs.org provides a new angle to the debate about the major health threat of antimicrobial resistance (AMR): the improper disposal of pharmaceutical waste by polluting factories in China, and their links with some of the world’s biggest pharmaceutical companies. The report raises the urgent need for antibiotic stewardship to avoid a looming public health disaster.
According to the report, polluting factories in (...)
The European Commission released its long-awaited Communication on a European Agenda on Migration on 13 May, thereby delivering one of President Juncker’s political priorities. While the likelihood of saving more migrants’ lives will be increased through increased funding for Frontex operations and a more coordinated effort to managing migration more fairly across Europe is welcome, the problem remains that reception conditions in EU countries are insufficient. Funding is (...)
Brussels, 05 May 2015 – What role can ethical recruitment play for fair distribution of health workers? What role does Europe have in ensuring that freedom of movement of health workers in the Single Market does not translate into unequitable access to health services in less affluent regions? These are some of the questions that today’s event, ‘Mobility of Health Professionals in the EU: Ethical Recruitment and Policy Coherence’ responded to.
Jointly organised by (...)
On 5 May 2015, Nessa Childers MEP (S&D, Ireland) will host an event co-organised by EPHA together with the Health Workers for All (HW4All) project and the European Federation of Public Service Unions (EPSU). This policy seminar, at the European Parliament in Brussels, is an opportunity to discuss the principles contained in the WHO Global Code of Practice on the International Recruitment of Health Personnel in the European context.
The event, ’Mobility of Health Professionals in (...)
In a recent public consultation, the European Medicines Agency (EMA) solicited stakeholders’ views about its draft proposal for a transparency addendum pertaining to the content of the EU portal and database that will be set up for the implementation of the Clinical Trial Regulation No 536/2014. The express aim of the latter is to provide more information on clinical trials and their result in Europe.
The consultation on the ’Draft proposal for an addendum, on transparency, to (...)
A new European Data in Health Research Alliance was launched in early December. This campaign, supported by a number of health organisations active across Europe and representing research, patient and public health concerns, was set up to demonstrate in the most tangible way that personal data in research is vital because it saves lives.
The Alliance was established by Cancer Research UK, the Medical Sciences Committee of Science Europe, European Patients’ Forum, the Federation of (...)
European AIDS Treatment Group and its members call on the pharmaceutical industry, governments and policy makers to show their commitment to improving access to a new Hepatitis C virus (HCV) drug.
Worldwide, about 150 million people suffer from chronic HCV. In 2010, HCV related mortality in the European Union was estimated at 57,000 with rates increasing. Hepatitis C is prevalent among people who inject drugs, patients after transfusions and health professionals.
A new revolutionary (...)